click below
click below
Normal Size Small Size show me how
Poisons/Antidotes
| Overdosed Drug | Symptoms/Diagnostic methods | Antidote(s) | MoA of Antidote | Special Considerations | Treatment Approach |
|---|---|---|---|---|---|
| acetaminophen | nausea/vomiting clinical signs of liver failure levels can be measured in the blood | N-acetylcysteine (NAC) | replenishes glutathione | antidote loses effectiveness 8 hours after OD, but should still administer past that point | toxicokinetic-based: enhancement of metabolism (detoxification) |
| toxic alcohols (methanol & ethylene glycol) | methanol active metabolites can cause anion-gap metabolic acidosis and ocular toxicity ethylene glycol metabolites can crystalize in microvasculature; common in renal toxicity | Ethanol or Fomepizole | inhibition of alcohol dehydrogenase (ADH) | Fomepizole is a stronger and safer ADH inhibitor with fewer ADRs than ethanol | toxicokinetic-based: inhibition of toxication (bioactivation) |
| benzodiazepines | CNS depression with relatively normal vitals levels can be measured in the blood | Flumazenil | competitive antagonist of benzodiazepine receptor | can cause withdrawal symptoms in a benzo-dependent patient | pharmacological treatment: receptor antagonist |
| beta blockers | hypotension, bradycardia, altered mental status, respiratory depression | Atropine, Calcium, Glucagon, HIET, Vasopressors, IFE | Atropine increases HR Calcium tries to drive Ca2+ into cardiac cells Glucagon increases cardiac cellular cAMP to increase HR HIET: mechanisms not understood Vasopressors: increase BP IV20%FE acts as lipid sink if drug is lipophilic enough | beta blocker OD may have altered mental status, CCBs do not | pharmacological treatments: receptor antagonist |
| calcium channel blockers | hypotension, bradycardia, but often alert | Atropine, Calcium, Glucagon, HIET, Vasopressors, IFE | Atropine increases HR Calcium tries to drive Ca2+ into cardiac cells Glucagon increases cardiac cellular cAMP to increase HR HIET: mechanisms not understood Vasopressors: increase BP IV20%FE acts as lipid sink if drug is lipophilic enough | pharmacological treatments: receptor antagonist | |
| digoxin | bradycardia, arrythmias, elevated serum K+, nausea/vomiting levels can be measured in the blood | Digoxin Specific Antibody Fragments (Fab) | binds digoxin and will be renally eliminated | checking serum digoxin levels after giving antidote is not helpful because total concentration (free + bound) will be increased can't be used as a measurement to calculate more Fab doses | inactvation of poisions: antivenoms/antibody binding |
| tricyclic antidepressants | tachycardia, dilated pupils, dry mouth, agitation, seizures, sometimes vasodilation, elongated QRS interval, reduced cardiac contractility | IV fluids, Dopamine or Norepinephrine, Sodium Bicarbonate for elongated QRS | mostly supportive care, trying to maintain BP Sodium bicarb counteracts inhibition of Na+ cardiac channels | ||
| opioids | somnolence, coma, decreased HR and RR, constricted pupiles | Nalxonone | competitive antagonist of opioid receptors | can trigger withdrawal | pharmacological treatment: receptor antagonist |
| salicylates (aspirin) | hyperventilation and respiratory alkalosis, then metabolic acidosis, hyperthermia, confusion and seizures | Supportive care, IV Sodium bicarbonate | renal ion trapping to enhance elimination | toxicokinetic-based: enhancement of elimination | |
| sulfonylureas & miglitinide | hypoglycemia | Octreotide | inhibits insulin release from the pancreas | toxicokinetic-based: inhibition of toxication (bioactivation) | |
| iron | vomiting/abdominal pain, and diarrhea within 1-6 hrs lethargy, coma, seizures, bloody vomiting, bloody diarrhea, and shock within 6-24 hrs hypotension and tachycardia within 6-24 hrs liver dysfunction and fsailure possible in 2-5 days | Deferoxamine | chelates the circulating ferric iron | inactivation of poisons: heavy metal chelator |